ASCO 2020: Pevonedistat Shows Promise In Higher-Risk MDS

Remission Rates Double At Phase II

 
• By Ian Haydock
  
Leukemia
New Hope For HR-MDS Patients? • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from ASCO

More from Conferences